Cite
HARVARD Citation
Liao, Z. et al. (2020). The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways. Journal of ethnopharmacology. p. . [Online].